Long-term follow-up in patients with moderate-to-severe atopic dermatitis treated with dupilumab

被引：0
|
作者：
Votto, M. [1 ]
Fortina, V. [1 ]
De Filippo, M. [1 ]
Naso, M. [1 ]
Villanova, M. [1 ]
Licari, A. [1 ]
Marseglia, G. L. [1 ]
Brazzelli, V. [1 ]
机构：
[1] Univ Pavia, Pavia, Italy
来源：
ALLERGY | 2023年 / 78卷
关键词：
D O I：
暂无
中图分类号：
R392 [医学免疫学];
学科分类号：
100102 ;
摘要：
000493
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Long-term follow-up and treatment outcomes of conjunctivitis during dupilumab treatment in patients with moderate-to-severe atopic dermatitis
    Achten, Roselie
    Bakker, Daphne
    Ariens, Lieneke
    Lans, Amanda
    Thijs, Judith
    Van der Schaft, Jorien
    De Boer, Joke
    Balak, Deepak
    De Graaf, Marlies
    Van Luijk, Chantal
    De Bruin-Weller, Marjolein
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE, 2021, 9 (03): : 1389 - +
  • [2] LONG-TERM SAFETY IN ADULTS WITH MODERATE-TO-SEVERE ATOPIC DERMATITIS TREATED WITH DUPILUMAB UP TO 4 YEARS
    Blauvelt, A.
    Eichenfield, L.
    Sierka, D.
    Chen, Z.
    Khokhar, F.
    Marco, A. Rodriguez
    Shabbir, A.
    ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2022, 129 : S19 - S19
  • [3] Emerging Role of Atopic Dermatitis Control Tool in Long-Term Monitoring of Patients With Moderate-to-Severe Atopic Dermatitis Treated With Dupilumab
    Cioppa, Vittoria
    Lazzeri, Laura
    Carraro, Andrea
    De Piano, Ernesto
    Falcinelli, Francesca
    Galluzzo, Marco
    Pallotta, Sabatino
    De Pita, Ornella
    Russo, Filomena
    DERMATITIS, 2024, 35
  • [4] Long-term psychological outcome of patients with moderate-to-severe atopic dermatitis continuously treated with Dupilumab: Data up to 3 years
    Miniotti, Marco
    Ribero, Simone
    Mastorino, Luca
    Ortoncelli, Michela
    Gelato, Federica
    Bailon, Mariagiulia
    Trioni, Jacopo
    Stefan, Beatrice
    Quaglino, Pietro
    Leombruni, Paolo
    EXPERIMENTAL DERMATOLOGY, 2023, 32 (06) : 852 - 858
  • [5] Long-term Dupilumab treatment up to 100 weeks reduces serum biomarkers in patients with moderate-to-severe atopic dermatitis
    Beck, Lisa A.
    Thaci, Diamant
    Bissonette, Robert
    Deleuran, Mette
    Harel, Sivan
    McDonald, Robert
    Shumel, Brad
    Rossi, Ana B.
    CLINICAL AND EXPERIMENTAL ALLERGY, 2021, 51 (01): : 168 - 168
  • [6] Long-term safety and efficacy of open-label dupilumab in patients with moderate-to-severe atopic dermatitis
    Deleuran, M.
    Thaci, D.
    Beck, L.
    Forman, S.
    Soong, W.
    Hussain, I.
    Bissonnette, R.
    Bouaziz, J.
    Gelfand, J.
    Lawrence, S.
    Chen, Z.
    Akinlade, B.
    Gadkari, A.
    Eckert, L.
    Graham, N.
    Ardeleanu, M.
    AUSTRALASIAN JOURNAL OF DERMATOLOGY, 2019, 60 : 34 - 34
  • [7] Long-Term Safety and Efficacy of Open-Label Dupilumab in Patients with Moderate-to-Severe Atopic Dermatitis
    Deleuran, Mette
    Thaci, Diamant
    Beck, Lisa A.
    Forman, Seth
    Soong, Weily
    Hussain, Iftikhar
    Bissonnette, Robert
    Bouaziz, Jean-David
    Gelfand, Joel
    Sher, Lawrence
    Chen, Zhen
    Akinlade, Bolanle
    Gadkari, Abhijit
    Eckert, Laurent
    Graham, Neil M. H.
    Pirozzi, Gianluca
    Ardeleanu, Marius
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2017, 139 (02) : AB381 - AB381
  • [8] Dupilumab provides long-term improvement in pruritus in children with severe atopic dermatitis and adolescents and adults with moderate-to-severe atopic dermatitis
    Cork, Michael J.
    Yosipovitch, Gil
    Silverberg, Jonathan I.
    Praestgaard, Amy
    Zhang, Haixin
    Wang, Zhixiao
    Rossi, Ana B.
    BRITISH JOURNAL OF DERMATOLOGY, 2022, 187 : 79 - 79
  • [9] Long-term dupilumab treatment up to 100 weeks has no impact on serum lipids in patients with moderate-to-severe atopic dermatitis
    Wollenberg, A.
    Bieber, T.
    Khokhar, F. A.
    Chen, Z.
    Shumel, B.
    Rossi, A. B.
    ALLERGY, 2020, 75 : 192 - 193
  • [10] Long-term dupilumab treatment up to 100 weeks reduces serum biomarkers in adult patients with moderate-to-severe atopic dermatitis
    Beck, L. A.
    Thaci, D.
    Bissonnette, R.
    Deleuran, M.
    Bastian, M.
    Harel, S.
    Chen, Z.
    Levit, N. A.
    Rossi, A. B.
    JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, 2021, 19 : 55 - 56
12345